|
HY-110246-10mg
|
MedChemexpress LLC
|
Quin C1 [CAS 786706-21-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-110246-25mg
|
MedChemexpress LLC
|
Quin C1 [CAS 786706-21-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-110246-5mg
|
MedChemexpress LLC
|
Quin C1 [CAS 786706-21-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-137872-1g
|
MedChemexpress LLC
|
L-Leucyl-4-nitroanilide (hydrochloride) [CAS 16010-98-3]
|
|
|
|
|
HY-137872-250mg
|
MedChemexpress LLC
|
L-Leucyl-4-nitroanilide (hydrochloride) [CAS 16010-98-3]
|
|
|
|
|
HY-O0004-100mg
|
MedChemexpress LLC
|
Collagenase I, from Clostridium histolyticum [CAS 9001-12-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-O0004-25mg
|
MedChemexpress LLC
|
Collagenase I, from Clostridium histolyticum [CAS 9001-12-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-O0004-50mg
|
MedChemexpress LLC
|
Collagenase I, from Clostridium histolyticum [CAS 9001-12-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P0122-1mg
|
MedChemexpress LLC
|
iRGD peptide [CAS 1392278-76-0]
|
|
Cancer-programmed cell death
|
|
|
HY-P0122-10mg
|
MedChemexpress LLC
|
iRGD peptide [CAS 1392278-76-0]
|
|
Cancer-programmed cell death
|
|
|
HY-P0122-5mg
|
MedChemexpress LLC
|
iRGD peptide [CAS 1392278-76-0]
|
|
Cancer-programmed cell death
|
|
|
HY-P1098-10mg
|
MedChemexpress LLC
|
Ac2-26 [CAS 151988-33-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1098-5mg
|
MedChemexpress LLC
|
Ac2-26 [CAS 151988-33-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1098-50mg
|
MedChemexpress LLC
|
Ac2-26 [CAS 151988-33-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-P2159-10mg
|
MedChemexpress LLC
|
Dynorphin A (1-8) [CAS 75790-53-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P2159-25mg
|
MedChemexpress LLC
|
Dynorphin A (1-8) [CAS 75790-53-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P2159-5mg
|
MedChemexpress LLC
|
Dynorphin A (1-8) [CAS 75790-53-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P2159-50mg
|
MedChemexpress LLC
|
Dynorphin A (1-8) [CAS 75790-53-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P2217-1mg
|
MedChemexpress LLC
|
Aclerastide [CAS 227803-63-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-P2217-10mg
|
MedChemexpress LLC
|
Aclerastide [CAS 227803-63-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-P2217-5mg
|
MedChemexpress LLC
|
Aclerastide [CAS 227803-63-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-P4094-10mg
|
MedChemexpress LLC
|
CTP [CAS 1052692-86-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P4094-25mg
|
MedChemexpress LLC
|
CTP [CAS 1052692-86-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P4094-5mg
|
MedChemexpress LLC
|
CTP [CAS 1052692-86-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P4094-50mg
|
MedChemexpress LLC
|
CTP [CAS 1052692-86-0]
|
|
Neuroscience-Neuromodulation
|
|
